RxDoctor Payments Data

David Porter, MD

Foot and Ankle Surgery · Carmel, INNPI 1194771501

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,633 of the $4,368 with a category attached, or 60.3%. Johnson & Johnson accounts for 63.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $1,768 and has fallen 92.5% since, to $133 in 2025. That places this record below the midpoint for foot and ankle surgery clinicians in IN, where the typical reported total is $4,256.

$4,368in general payments, 2019–2025

Across 27 payments — averaging $161.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$3K
  • Novastep Inc.$536
  • Globus Medical$386
  • Paragon 28, Inc.$363
  • Stryker$160
  • Arthrex$46
  • plus $117 from 6 others

What the payments were for

  • Consulting fees$2,63360%
  • Travel & lodging$2546%
  • Food & beverage$1,40332%
  • Gifts$792%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,368 in reported general payments places this provider in the 50th percentile of 212 foot and ankle surgery providers in Indiana.

See all foot and ankle surgery providers in Indiana →

Medicare billing

Part B allowed, 2024
$44,149
Medicare patients
175
Services billed
707

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin46$373

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Carmel

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →